Dasatinib: an inhibitor of tyrosine kinase (ITK) effective in acute transformations of CML and in Ph

被引：0
|
作者：
Rousselot, Philippe
机构：
来源：
HEMATOLOGIE | 2007年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：282 / 283
页数：3
相关论文
共 50 条
  • [31] Dasatinib is more effective than imatinib in inhibiting Bcr-Abl and Src-tyrosine kinase activity in CML progenitors, but not in inducing growth inhibition
    Konig, H.
    Jove, R.
    Holyoake, T.
    Bhatia, R.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 66 - 66
  • [32] The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma
    da Silva, A. L.
    Magalhaes, R. F.
    Branco, V. C.
    Silva, J. D.
    Cruz, F. F.
    Marques, P. S.
    Ferreira, T. P. T.
    Morales, M. M.
    Martins, M. A.
    Olsen, P. C.
    Rocco, P. R. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (07) : 1236 - 1247
  • [33] Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model
    Vitali, Roberta
    Mancini, Camillo
    Cesi, Vincenzo
    Tanno, Barbara
    Piscitelli, Marta
    Mancuso, Mariateresa
    Sesti, Fabiola
    Pasquali, Emanuela
    Calabretta, Bruno
    Dominici, Carlo
    Raschella, Giuseppe
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (11) : 2547 - 2555
  • [34] Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis
    Guo, Kai
    Bu, Xin
    Yang, Chongfei
    Cao, Xiaorui
    Bian, Huan
    Zhu, Qingsheng
    Zhu, Jinyu
    Zhang, Dawei
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [35] The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis
    Can, G.
    Ayvaz, S.
    Can, H.
    Karaboga, I.
    Demirtas, S.
    Aksit, H.
    Yilmaz, B.
    Korkmaz, U.
    Kurt, M.
    Karaca, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S126 - S127
  • [36] The Tyrosine Kinase Inhibitor Dasatinib impedes adaptive cell surveillance in peripheral lymph nodes
    Carvoeiro, Daniela Claudino
    Marcos-Jimenez, Ana
    Munoz-Calleja, Cecilia
    Stein, Jens Volker
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1099 - 1099
  • [37] The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
    Mestermann, Katrin
    Giavridis, Theodoros
    Weber, Justus
    Rydzek, Julian
    Frenz, Silke
    Nerreter, Thomas
    Mades, Andreas
    Sadelain, Michel
    Einsele, Hermann
    Hudecek, Michael
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (499)
  • [38] The Tyrosine Kinase Inhibitor Dasatinib Dysregulates Bone Remodeling Through Inhibition of Osteoclasts In Vivo
    Vandyke, Kate
    Dewar, Andrea L.
    Diamond, Peter
    Fitter, Stephen
    Schultz, Christopher G.
    Sims, Natalie A.
    Zannettino, Andrew C. W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (08) : 1759 - 1770
  • [39] Pulmonary hypertension (PH) in patients (pts) with CML treated with tyrosine kinase inhibitors (TKIs).
    Gaballa, S.
    Al-Kali, A.
    Kantarjian, H.
    Jabbour, E.
    Quintas-Cardama, A.
    Ayoubi, M.
    Borthakur, G.
    O'Brien, S. M.
    Cortes, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] CML Patients Show Sperm Alterations At Diagnosis That Are Not Improved On Tyrosine Kinase Inhibitor Treatment
    Nicolini, Franck E.
    Huguet, Francoise
    Labussiere-Wallet, Helene
    Guillermin, Yann
    Etienne, Madeleine
    Fort, Marie-Pierre
    Tigaud, Isabelle
    Hayette, Sandrine
    Morisset, Stephane
    Sobh, Mohamad
    Barraco, Fiorenza
    Michallet, Mauricette
    Daudin, Myriam
    Soula, Volcy
    d'Estaing, Sandrine Giscard
    Etienne, Gabriel
    BLOOD, 2012, 120 (21)
12345